Cargando…
Microchamber Cultures of Bladder Cancer: A Platform for Characterizing Drug Responsiveness and Resistance in PDX and Primary Cancer Cells
Precision cancer medicine seeks to target the underlying genetic alterations of cancer; however, it has been challenging to use genetic profiles of individual patients in identifying the most appropriate anti-cancer drugs. This spurred the development of patient avatars; for example, patient-derived...
Autores principales: | Gheibi, Pantea, Zeng, Shuxiong, Son, Kyung Jin, Vu, Tam, Ma, Ai-Hong, Dall’Era, Marc A., Yap, Stanley Alexander, de Vere White, Ralph W., Pan, Chong-Xian, Revzin, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612935/ https://www.ncbi.nlm.nih.gov/pubmed/28947782 http://dx.doi.org/10.1038/s41598-017-12543-9 |
Ejemplares similares
-
Detecting cell-secreted growth factors in microfluidic devices using bead-based biosensors
por: Son, Kyung Jin, et al.
Publicado: (2017) -
Effect of Neoadjuvant Chemotherapy on Renal Function following Radical Cystectomy: Is there a Meaningful Impact?
por: Chandrasekar, Thenappan, et al.
Publicado: (2016) -
Active Surveillance for Intermediate Risk Prostate Cancer
por: Dall'Era, Marc A., et al.
Publicado: (2016) -
Indications for and transitioning to secondary treatment while on active surveillance for prostate cancer
por: Glass, Allison S., et al.
Publicado: (2018) -
Ductular reaction-on-a-chip: Microfluidic co-cultures to study stem cell fate selection during liver injury
por: Haque, Amranul, et al.
Publicado: (2016)